1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Nuclear Medicine Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Radium-223 1.2.3 Lutetium-177 1.2.4 Iodine-131 1.2.5 Other 1.3 Market by Application 1.3.1 Global Nuclear Medicine Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Thyroid 1.3.3 Bone Metastasis 1.3.4 Lymphoma 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Nuclear Medicine Therapy Market Perspective (2017-2028) 2.2 Nuclear Medicine Therapy Growth Trends by Region 2.2.1 Nuclear Medicine Therapy Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Nuclear Medicine Therapy Historic Market Size by Region (2017-2022) 2.2.3 Nuclear Medicine Therapy Forecasted Market Size by Region (2023-2028) 2.3 Nuclear Medicine Therapy Market Dynamics 2.3.1 Nuclear Medicine Therapy Industry Trends 2.3.2 Nuclear Medicine Therapy Market Drivers 2.3.3 Nuclear Medicine Therapy Market Challenges 2.3.4 Nuclear Medicine Therapy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Nuclear Medicine Therapy Players by Revenue 3.1.1 Global Top Nuclear Medicine Therapy Players by Revenue (2017-2022) 3.1.2 Global Nuclear Medicine Therapy Revenue Market Share by Players (2017-2022) 3.2 Global Nuclear Medicine Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Nuclear Medicine Therapy Revenue 3.4 Global Nuclear Medicine Therapy Market Concentration Ratio 3.4.1 Global Nuclear Medicine Therapy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Therapy Revenue in 2021 3.5 Nuclear Medicine Therapy Key Players Head office and Area Served 3.6 Key Players Nuclear Medicine Therapy Product Solution and Service 3.7 Date of Enter into Nuclear Medicine Therapy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Nuclear Medicine Therapy Breakdown Data by Type 4.1 Global Nuclear Medicine Therapy Historic Market Size by Type (2017-2022) 4.2 Global Nuclear Medicine Therapy Forecasted Market Size by Type (2023-2028) 5 Nuclear Medicine Therapy Breakdown Data by Application 5.1 Global Nuclear Medicine Therapy Historic Market Size by Application (2017-2022) 5.2 Global Nuclear Medicine Therapy Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Nuclear Medicine Therapy Market Size (2017-2028) 6.2 North America Nuclear Medicine Therapy Market Size by Type 6.2.1 North America Nuclear Medicine Therapy Market Size by Type (2017-2022) 6.2.2 North America Nuclear Medicine Therapy Market Size by Type (2023-2028) 6.2.3 North America Nuclear Medicine Therapy Market Share by Type (2017-2028) 6.3 North America Nuclear Medicine Therapy Market Size by Application 6.3.1 North America Nuclear Medicine Therapy Market Size by Application (2017-2022) 6.3.2 North America Nuclear Medicine Therapy Market Size by Application (2023-2028) 6.3.3 North America Nuclear Medicine Therapy Market Share by Application (2017-2028) 6.4 North America Nuclear Medicine Therapy Market Size by Country 6.4.1 North America Nuclear Medicine Therapy Market Size by Country (2017-2022) 6.4.2 North America Nuclear Medicine Therapy Market Size by Country (2023-2028) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Nuclear Medicine Therapy Market Size (2017-2028) 7.2 Europe Nuclear Medicine Therapy Market Size by Type 7.2.1 Europe Nuclear Medicine Therapy Market Size by Type (2017-2022) 7.2.2 Europe Nuclear Medicine Therapy Market Size by Type (2023-2028) 7.2.3 Europe Nuclear Medicine Therapy Market Share by Type (2017-2028) 7.3 Europe Nuclear Medicine Therapy Market Size by Application 7.3.1 Europe Nuclear Medicine Therapy Market Size by Application (2017-2022) 7.3.2 Europe Nuclear Medicine Therapy Market Size by Application (2023-2028) 7.3.3 Europe Nuclear Medicine Therapy Market Share by Application (2017-2028) 7.4 Europe Nuclear Medicine Therapy Market Size by Country 7.4.1 Europe Nuclear Medicine Therapy Market Size by Country (2017-2022) 7.4.2 Europe Nuclear Medicine Therapy Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Nuclear Medicine Therapy Market Size (2017-2028) 8.2 Asia-Pacific Nuclear Medicine Therapy Market Size by Type 8.2.1 Asia-Pacific Nuclear Medicine Therapy Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Nuclear Medicine Therapy Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Nuclear Medicine Therapy Market Share by Type (2017-2028) 8.3 Asia-Pacific Nuclear Medicine Therapy Market Size by Application 8.3.1 Asia-Pacific Nuclear Medicine Therapy Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Nuclear Medicine Therapy Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Nuclear Medicine Therapy Market Share by Application (2017-2028) 8.4 Asia-Pacific Nuclear Medicine Therapy Market Size by Region 8.4.1 Asia-Pacific Nuclear Medicine Therapy Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Nuclear Medicine Therapy Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Nuclear Medicine Therapy Market Size (2017-2028) 9.2 Latin America Nuclear Medicine Therapy Market Size by Type 9.2.1 Latin America Nuclear Medicine Therapy Market Size by Type (2017-2022) 9.2.2 Latin America Nuclear Medicine Therapy Market Size by Type (2023-2028) 9.2.3 Latin America Nuclear Medicine Therapy Market Share by Type (2017-2028) 9.3 Latin America Nuclear Medicine Therapy Market Size by Application 9.3.1 Latin America Nuclear Medicine Therapy Market Size by Application (2017-2022) 9.3.2 Latin America Nuclear Medicine Therapy Market Size by Application (2023-2028) 9.3.3 Latin America Nuclear Medicine Therapy Market Share by Application (2017-2028) 9.4 Latin America Nuclear Medicine Therapy Market Size by Country 9.4.1 Latin America Nuclear Medicine Therapy Market Size by Country (2017-2022) 9.4.2 Latin America Nuclear Medicine Therapy Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Nuclear Medicine Therapy Market Size (2017-2028) 10.2 Middle East & Africa Nuclear Medicine Therapy Market Size by Type 10.2.1 Middle East & Africa Nuclear Medicine Therapy Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Nuclear Medicine Therapy Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Nuclear Medicine Therapy Market Share by Type (2017-2028) 10.3 Middle East & Africa Nuclear Medicine Therapy Market Size by Application 10.3.1 Middle East & Africa Nuclear Medicine Therapy Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Nuclear Medicine Therapy Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Nuclear Medicine Therapy Market Share by Application (2017-2028) 10.4 Middle East & Africa Nuclear Medicine Therapy Market Size by Country 10.4.1 Middle East & Africa Nuclear Medicine Therapy Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Nuclear Medicine Therapy Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Novartis 11.1.1 Novartis Company Details 11.1.2 Novartis Business Overview 11.1.3 Novartis Nuclear Medicine Therapy Introduction 11.1.4 Novartis Revenue in Nuclear Medicine Therapy Business (2017-2022) 11.1.5 Novartis Recent Developments 11.2 Bayer 11.2.1 Bayer Company Details 11.2.2 Bayer Business Overview 11.2.3 Bayer Nuclear Medicine Therapy Introduction 11.2.4 Bayer Revenue in Nuclear Medicine Therapy Business (2017-2022) 11.2.5 Bayer Recent Developments 11.3 China Isotope & Radiation 11.3.1 China Isotope & Radiation Company Details 11.3.2 China Isotope & Radiation Business Overview 11.3.3 China Isotope & Radiation Nuclear Medicine Therapy Introduction 11.3.4 China Isotope & Radiation Revenue in Nuclear Medicine Therapy Business (2017-2022) 11.3.5 China Isotope & Radiation Recent Developments 11.4 Q BioMed 11.4.1 Q BioMed Company Details 11.4.2 Q BioMed Business Overview 11.4.3 Q BioMed Nuclear Medicine Therapy Introduction 11.4.4 Q BioMed Revenue in Nuclear Medicine Therapy Business (2017-2022) 11.4.5 Q BioMed Recent Developments 11.5 Curium Pharmaceuticals 11.5.1 Curium Pharmaceuticals Company Details 11.5.2 Curium Pharmaceuticals Business Overview 11.5.3 Curium Pharmaceuticals Nuclear Medicine Therapy Introduction 11.5.4 Curium Pharmaceuticals Revenue in Nuclear Medicine Therapy Business (2017-2022) 11.5.5 Curium Pharmaceuticals Recent Developments 11.6 Jubilant DraxImage 11.6.1 Jubilant DraxImage Company Details 11.6.2 Jubilant DraxImage Business Overview 11.6.3 Jubilant DraxImage Nuclear Medicine Therapy Introduction 11.6.4 Jubilant DraxImage Revenue in Nuclear Medicine Therapy Business (2017-2022) 11.6.5 Jubilant DraxImage Recent Developments 11.7 Dongcheng 11.7.1 Dongcheng Company Details 11.7.2 Dongcheng Business Overview 11.7.3 Dongcheng Nuclear Medicine Therapy Introduction 11.7.4 Dongcheng Revenue in Nuclear Medicine Therapy Business (2017-2022) 11.7.5 Dongcheng Recent Developments 11.8 Lantheus 11.8.1 Lantheus Company Details 11.8.2 Lantheus Business Overview 11.8.3 Lantheus Nuclear Medicine Therapy Introduction 11.8.4 Lantheus Revenue in Nuclear Medicine Therapy Business (2017-2022) 11.8.5 Lantheus Recent Developments 11.9 Acrotech Biopharma. 11.9.1 Acrotech Biopharma. Company Details 11.9.2 Acrotech Biopharma. Business Overview 11.9.3 Acrotech Biopharma. Nuclear Medicine Therapy Introduction 11.9.4 Acrotech Biopharma. Revenue in Nuclear Medicine Therapy Business (2017-2022) 11.9.5 Acrotech Biopharma. Recent Developments 11.10 Progenics Pharmaceuticals 11.10.1 Progenics Pharmaceuticals Company Details 11.10.2 Progenics Pharmaceuticals Business Overview 11.10.3 Progenics Pharmaceuticals Nuclear Medicine Therapy Introduction 11.10.4 Progenics Pharmaceuticals Revenue in Nuclear Medicine Therapy Business (2017-2022) 11.10.5 Progenics Pharmaceuticals Recent Developments 11.11 International Isotopes 11.11.1 International Isotopes Company Details 11.11.2 International Isotopes Business Overview 11.11.3 International Isotopes Nuclear Medicine Therapy Introduction 11.11.4 International Isotopes Revenue in Nuclear Medicine Therapy Business (2017-2022) 11.11.5 International Isotopes Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Nuclear Medicine Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Radium-223 Table 3. Key Players of Lutetium-177 Table 4. Key Players of Iodine-131 Table 5. Key Players of Other Table 6. Global Nuclear Medicine Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 7. Global Nuclear Medicine Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Nuclear Medicine Therapy Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Nuclear Medicine Therapy Market Share by Region (2017-2022) Table 10. Global Nuclear Medicine Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Nuclear Medicine Therapy Market Share by Region (2023-2028) Table 12. Nuclear Medicine Therapy Market Trends Table 13. Nuclear Medicine Therapy Market Drivers Table 14. Nuclear Medicine Therapy Market Challenges Table 15. Nuclear Medicine Therapy Market Restraints Table 16. Global Nuclear Medicine Therapy Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Nuclear Medicine Therapy Revenue Share by Players (2017-2022) Table 18. Global Top Nuclear Medicine Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Therapy as of 2021) Table 19. Ranking of Global Top Nuclear Medicine Therapy Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Nuclear Medicine Therapy Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Nuclear Medicine Therapy Product Solution and Service Table 23. Date of Enter into Nuclear Medicine Therapy Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Nuclear Medicine Therapy Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Nuclear Medicine Therapy Revenue Market Share by Type (2017-2022) Table 27. Global Nuclear Medicine Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Nuclear Medicine Therapy Revenue Market Share by Type (2023-2028) Table 29. Global Nuclear Medicine Therapy Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Nuclear Medicine Therapy Revenue Share by Application (2017-2022) Table 31. Global Nuclear Medicine Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Nuclear Medicine Therapy Revenue Share by Application (2023-2028) Table 33. North America Nuclear Medicine Therapy Market Size by Type (2017-2022) & (US$ Million) Table 34. North America Nuclear Medicine Therapy Market Size by Type (2023-2028) & (US$ Million) Table 35. North America Nuclear Medicine Therapy Market Size by Application (2017-2022) & (US$ Million) Table 36. North America Nuclear Medicine Therapy Market Size by Application (2023-2028) & (US$ Million) Table 37. North America Nuclear Medicine Therapy Market Size by Country (2017-2022) & (US$ Million) Table 38. North America Nuclear Medicine Therapy Market Size by Country (2023-2028) & (US$ Million) Table 39. Europe Nuclear Medicine Therapy Market Size by Type (2017-2022) & (US$ Million) Table 40. Europe Nuclear Medicine Therapy Market Size by Type (2023-2028) & (US$ Million) Table 41. Europe Nuclear Medicine Therapy Market Size by Application (2017-2022) & (US$ Million) Table 42. Europe Nuclear Medicine Therapy Market Size by Application (2023-2028) & (US$ Million) Table 43. Europe Nuclear Medicine Therapy Market Size by Country (2017-2022) & (US$ Million) Table 44. Europe Nuclear Medicine Therapy Market Size by Country (2023-2028) & (US$ Million) Table 45. Asia Pacific Nuclear Medicine Therapy Market Size by Type (2017-2022) & (US$ Million) Table 46. Asia Pacific Nuclear Medicine Therapy Market Size by Type (2023-2028) & (US$ Million) Table 47. Asia Pacific Nuclear Medicine Therapy Market Size by Application (2017-2022) & (US$ Million) Table 48. Asia Pacific Nuclear Medicine Therapy Market Size by Application (2023-2028) & (US$ Million) Table 49. Asia Pacific Nuclear Medicine Therapy Market Size by Region (2017-2022) & (US$ Million) Table 50. Asia Pacific Nuclear Medicine Therapy Market Size by Region (2023-2028) & (US$ Million) Table 51. Latin America Nuclear Medicine Therapy Market Size by Type (2017-2022) & (US$ Million) Table 52. Latin America Nuclear Medicine Therapy Market Size by Type (2023-2028) & (US$ Million) Table 53. Latin America Nuclear Medicine Therapy Market Size by Application (2017-2022) & (US$ Million) Table 54. Latin America Nuclear Medicine Therapy Market Size by Application (2023-2028) & (US$ Million) Table 55. Latin America Nuclear Medicine Therapy Market Size by Country (2017-2022) & (US$ Million) Table 56. Latin America Nuclear Medicine Therapy Market Size by Country (2023-2028) & (US$ Million) Table 57. Middle East and Africa Nuclear Medicine Therapy Market Size by Type (2017-2022) & (US$ Million) Table 58. Middle East and Africa Nuclear Medicine Therapy Market Size by Type (2023-2028) & (US$ Million) Table 59. Middle East and Africa Nuclear Medicine Therapy Market Size by Application (2017-2022) & (US$ Million) Table 60. Middle East and Africa Nuclear Medicine Therapy Market Size by Application (2023-2028) & (US$ Million) Table 61. Middle East and Africa Nuclear Medicine Therapy Market Size by Country (2017-2022) & (US$ Million) Table 62. Middle East and Africa Nuclear Medicine Therapy Market Size by Country (2023-2028) & (US$ Million) Table 63. Novartis Company Details Table 64. Novartis Business Overview Table 65. Novartis Nuclear Medicine Therapy Product Table 66. Novartis Revenue in Nuclear Medicine Therapy Business (2017-2022) & (US$ Million) Table 67. Novartis Recent Developments Table 68. Bayer Company Details Table 69. Bayer Business Overview Table 70. Bayer Nuclear Medicine Therapy Product Table 71. Bayer Revenue in Nuclear Medicine Therapy Business (2017-2022) & (US$ Million) Table 72. Bayer Recent Developments Table 73. China Isotope & Radiation Company Details Table 74. China Isotope & Radiation Business Overview Table 75. China Isotope & Radiation Nuclear Medicine Therapy Product Table 76. China Isotope & Radiation Revenue in Nuclear Medicine Therapy Business (2017-2022) & (US$ Million) Table 77. China Isotope & Radiation Recent Developments Table 78. Q BioMed Company Details Table 79. Q BioMed Business Overview Table 80. Q BioMed Nuclear Medicine Therapy Product Table 81. Q BioMed Revenue in Nuclear Medicine Therapy Business (2017-2022) & (US$ Million) Table 82. Q BioMed Recent Developments Table 83. Curium Pharmaceuticals Company Details Table 84. Curium Pharmaceuticals Business Overview Table 85. Curium Pharmaceuticals Nuclear Medicine Therapy Product Table 86. Curium Pharmaceuticals Revenue in Nuclear Medicine Therapy Business (2017-2022) & (US$ Million) Table 87. Curium Pharmaceuticals Recent Developments Table 88. Jubilant DraxImage Company Details Table 89. Jubilant DraxImage Business Overview Table 90. Jubilant DraxImage Nuclear Medicine Therapy Product Table 91. Jubilant DraxImage Revenue in Nuclear Medicine Therapy Business (2017-2022) & (US$ Million) Table 92. Jubilant DraxImage Recent Developments Table 93. Dongcheng Company Details Table 94. Dongcheng Business Overview Table 95. Dongcheng Nuclear Medicine Therapy Product Table 96. Dongcheng Revenue in Nuclear Medicine Therapy Business (2017-2022) & (US$ Million) Table 97. Dongcheng Recent Developments Table 98. Lantheus Company Details Table 99. Lantheus Business Overview Table 100. Lantheus Nuclear Medicine Therapy Product Table 101. Lantheus Revenue in Nuclear Medicine Therapy Business (2017-2022) & (US$ Million) Table 102. Lantheus Recent Developments Table 103. Acrotech Biopharma. Company Details Table 104. Acrotech Biopharma. Business Overview Table 105. Acrotech Biopharma. Nuclear Medicine Therapy Product Table 106. Acrotech Biopharma. Revenue in Nuclear Medicine Therapy Business (2017-2022) & (US$ Million) Table 107. Acrotech Biopharma. Recent Developments Table 108. Progenics Pharmaceuticals Company Details Table 109. Progenics Pharmaceuticals Business Overview Table 110. Progenics Pharmaceuticals Nuclear Medicine Therapy Product Table 111. Progenics Pharmaceuticals Revenue in Nuclear Medicine Therapy Business (2017-2022) & (US$ Million) Table 112. Progenics Pharmaceuticals Recent Developments Table 113. International Isotopes Company Details Table 114. International Isotopes Business Overview Table 115. International Isotopes Nuclear Medicine Therapy Product Table 116. International Isotopes Revenue in Nuclear Medicine Therapy Business (2017-2022) & (US$ Million) Table 117. International Isotopes Recent Developments Table 118. Research Programs/Design for This Report Table 119. Key Data Information from Secondary Sources Table 120. Key Data Information from Primary Sources List of Figures Figure 1. Global Nuclear Medicine Therapy Market Share by Type: 2021 VS 2028 Figure 2. Radium-223 Features Figure 3. Lutetium-177 Features Figure 4. Iodine-131 Features Figure 5. Other Features Figure 6. Global Nuclear Medicine Therapy Market Share by Application: 2021 VS 2028 Figure 7. Thyroid Case Studies Figure 8. Bone Metastasis Case Studies Figure 9. Lymphoma Case Studies Figure 10. Other Case Studies Figure 11. Nuclear Medicine Therapy Report Years Considered Figure 12. Global Nuclear Medicine Therapy Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 13. Global Nuclear Medicine Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 14. Global Nuclear Medicine Therapy Market Share by Region: 2021 VS 2028 Figure 15. Global Nuclear Medicine Therapy Market Share by Players in 2021 Figure 16. Global Top Nuclear Medicine Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Therapy as of 2021) Figure 17. The Top 10 and 5 Players Market Share by Nuclear Medicine Therapy Revenue in 2021 Figure 18. North America Nuclear Medicine Therapy Market Size YoY (2017-2028) & (US$ Million) Figure 19. North America Nuclear Medicine Therapy Market Size Market Share by Type (2017-2028) Figure 20. North America Nuclear Medicine Therapy Market Size Market Share by Application (2017-2028) Figure 21. North America Nuclear Medicine Therapy Market Size Share by Country (2017-2028) Figure 22. United States Nuclear Medicine Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Canada Nuclear Medicine Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Europe Nuclear Medicine Therapy Market Size YoY (2017-2028) & (US$ Million) Figure 25. Europe Nuclear Medicine Therapy Market Size Market Share by Type (2017-2028) Figure 26. Europe Nuclear Medicine Therapy Market Size Market Share by Application (2017-2028) Figure 27. Europe Nuclear Medicine Therapy Market Size Share by Country (2017-2028) Figure 28. Germany Nuclear Medicine Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. France Nuclear Medicine Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. U.K. Nuclear Medicine Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Italy Nuclear Medicine Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Russia Nuclear Medicine Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Nordic Countries Nuclear Medicine Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Nuclear Medicine Therapy Market Size YoY (2017-2028) & (US$ Million) Figure 35. Asia Pacific Nuclear Medicine Therapy Market Size Market Share by Type (2017-2028) Figure 36. Asia Pacific Nuclear Medicine Therapy Market Size Market Share by Application (2017-2028) Figure 37. Asia Pacific Nuclear Medicine Therapy Market Size Share by Region (2017-2028) Figure 38. China Nuclear Medicine Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Japan Nuclear Medicine Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. South Korea Nuclear Medicine Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Southeast Asia Nuclear Medicine Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. India Nuclear Medicine Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Australia Nuclear Medicine Therapy Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 44. Latin America Nuclear Medicine Therapy Market Size YoY (2017-2028) & (US$ Million) Figure 45. Latin America Nuclear Medicine Therapy Market Size Market Share by Type (2017-2028) Figure 46. Latin America Nuclear Medicine Therapy Market Size Market Share by Application (2017-2028) Figure 47. Latin America Nuclear Medicine Therapy Market Size Share by Country (2017-2028) Figure 48. Mexico Nuclear Medicine Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Brazil Nuclear Medicine Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 50. Middle East & Africa Nuclear Medicine Therapy Market Size YoY (2017-2028) & (US$ Million) Figure 51. Middle East and Africa Nuclear Medicine Therapy Market Size Market Share by Type (2017-2028) Figure 52. Middle East and Africa Nuclear Medicine Therapy Market Size Market Share by Application (2017-2028) Figure 53. Middle East and Africa Nuclear Medicine Therapy Market Size Share by Country (2017-2028) Figure 54. Turkey Nuclear Medicine Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. Saudi Arabia Nuclear Medicine Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. UAE Nuclear Medicine Therapy Market Size YoY Growth (2017-2028) & (US$ Million) Figure 57. Novartis Revenue Growth Rate in Nuclear Medicine Therapy Business (2017-2022) Figure 58. Bayer Revenue Growth Rate in Nuclear Medicine Therapy Business (2017-2022) Figure 59. China Isotope & Radiation Revenue Growth Rate in Nuclear Medicine Therapy Business (2017-2022) Figure 60. Q BioMed Revenue Growth Rate in Nuclear Medicine Therapy Business (2017-2022) Figure 61. Curium Pharmaceuticals Revenue Growth Rate in Nuclear Medicine Therapy Business (2017-2022) Figure 62. Jubilant DraxImage Revenue Growth Rate in Nuclear Medicine Therapy Business (2017-2022) Figure 63. Dongcheng Revenue Growth Rate in Nuclear Medicine Therapy Business (2017-2022) Figure 64. Lantheus Revenue Growth Rate in Nuclear Medicine Therapy Business (2017-2022) Figure 65. Acrotech Biopharma. Revenue Growth Rate in Nuclear Medicine Therapy Business (2017-2022) Figure 66. Progenics Pharmaceuticals Revenue Growth Rate in Nuclear Medicine Therapy Business (2017-2022) Figure 67. International Isotopes Revenue Growth Rate in Nuclear Medicine Therapy Business (2017-2022) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

Novartis Bayer China Isotope & Radiation Q BioMed Curium Pharmaceuticals Jubilant DraxImage Dongcheng Lantheus Acrotech Biopharma. Progenics Pharmaceuticals International Isotopes